The Impact of Fluorescence in situ Hybridization on the Staging of Upper Tract Urothelial Carcinoma.


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2021
Historique:
received: 28 09 2020
accepted: 28 11 2020
pubmed: 15 2 2021
medline: 25 11 2021
entrez: 14 2 2021
Statut: ppublish

Résumé

The aim of the study was to evaluate the impact of fluorescence in situ hybridization (FISH) diagnostics on the T stage in final histology specimen of patients undergoing radical nephroureterectomy (RNU) due to upper tract urothelial carcinoma (UTUC) at a large tertiary care center. We retrospectively analyzed patients who underwent RNU at our center between 2008 and 2020. Inclusion criteria were RNU due to UTUC. Urine cytologies were used for FISH analysis to detect chromosomal abnormalities. Pre-FISH group was defined as patients without access to routine preoperative urinary FISH testing (2008-2014), and FISH group was defined as patients with access to routine FISH testing. Primary outcome was T stage in final histology. Statistical analysis was performed by χ2 test and Mann-Whitney U test. Out of 212 patients who underwent RNU at our center between 2008 and 2020, 155 patients were included into the final analysis. The median age was 71 (range 33-90) years, and 108 (69.7%) patients were male and 47 (30.3%) female. Age and gender were not differently distributed in both groups (age: p = 0.925; gender: p = 0.682). Organ-confined disease was found in 37/72 patients in the pre-FISH cohort and in 48/83 patients in the FISH cohort (p = 0.422). Within organ-confined disease, 18/37 patients revealed a T stage smaller than T1 in the pre-FISH cohort and 35/48 patients in the FISH cohort (p = 0.022). Preoperative FISH diagnostics add important information to preoperative diagnostic workup of patients with UTUC. Within organ-confined disease, a significant shift toward T stages lower than T1 is observed. Further research is required to determine the impact of this shift on survival in UTUC.

Identifiants

pubmed: 33582671
pii: 000513459
doi: 10.1159/000513459
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

631-636

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Lennert Eismann (L)

Department of Urology, Klinikum der Universität München, Munich, Germany, lennert.eismann@gmx.net.

Jan-Niclas Mumm (JN)

Department of Urology, Klinikum der Universität München, Munich, Germany.

Lucas Bohn (L)

Department of Urology, Klinikum der Universität München, Munich, Germany.

Christian Wülfing (C)

Department of Urology, Asklepios Klinik Hamburg Altona, Hamburg, Germany.

Ruth Knüchel-Clarke (R)

Institute of Pathology, Uniklinik RWTH Aachen, Aachen, Germany.

Jozefina Casuscelli (J)

Department of Urology, Klinikum der Universität München, Munich, Germany.

Raphaela Waidelich (R)

Department of Urology, Klinikum der Universität München, Munich, Germany.

Christian G Stief (CG)

Department of Urology, Klinikum der Universität München, Munich, Germany.

Boris Schlenker (B)

Department of Urology, Klinikum der Universität München, Munich, Germany.

Severin Rodler (S)

Department of Urology, Klinikum der Universität München, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH